Consumer Borrowing Drops, Markets Mixed
On the upside
Shares of Verisk (Nasdaq: VRSK) surged on its first day of trading.
Avanir Pharmaceuticals (Nasdaq: AVNR) will receive a new patent for its neurological disorder medication Zenvia.
Friedman, Billings, Ramsey analyst Adrienne Tennant lifted her price target for Talbots (NYSE: TLB) citing efforts by the company to improve operations.
On the downside
Standard Pacific (NYSE: SPF) will release third quarter earnings after market close on Thursday October 29, 2009.
Allos Therapeutics (Nasdaq: ALTH) increased the size of its offering to 14 million shares.
Sprint (NYSE: S) settled five shareholder lawsuits opposing the company's plan to purhase of Virgin Mobile USA.
In the broad market, advancing issues outpaced decliners by a margin of nearly 5 to 4 on the NYSE while decliners barely edged out advancers by a slim margin on Nasdaq. The Russell 2000 which tracks small cap stocks edged up a point to 602.

